,,iv  #aag? ,,congress  #a/ ,session    
,h4 ,,con4 ,,res4 #fj  ,,9 ,,! ,,h\se   
,,( ,,repres5tatives  ,novemb] #i1      
#bjba,ms4 ,s*ak[sky 7= h]self1 ,mr4     
,blum5au]1 ,ms4 ,de,lauro1 ,mr4         
,doggett1 ,mr4 ,ca/ro ( ,texas1 ,mr4    
,espaillat1 ,mr4 ,g>ca ( ,ill9ois1 ,ms4 
,lee ( ,cali=nia1 ,ms4 ,jacobs (        
,cali=nia1 ,mr4 ,khanna1 ,mr4           
,kri%namoor?i1 ,mr4 ,pocan1 & ,ms4      
,pressley7 submitt$ ! foll[+ concurr5t  
resolution2 :i* 0 ref]r$ to ! ,committee
 on ,=eign ,affairs1 & 9 addition to !  
,committees on ,ways & ,means1 !        
,judici>y1 & ,f9ancial ,s]vices1 = a    
p]iod to be subsequ5tly det]m9$ by !    
,speak]1 9 ea* case = consid]ation ( su*
 provisions z fall )9 ! jurisdiction ( !
 committee conc]n$  ,,concurr5t         
,,resolution  ,express+ ! s5se (        
,congress t ! ,unit$ ,/ates ,gov]nm5t   
mu/ take /eps to end ! p&emic n[4       
,:]eas ! extraord9>y circum/ances ( !   
,,covid-#ai p&emic call = extraord9>y   
measures by _w lead]s :o mu/ *oose to   

end ! p&emic & act accord+ly2 ,:]eas !  
,delta v>iant t 0 fir/ detect$ 9 ,india 
& increas$ ,,covid-#ai dea?s worldwide1 
mak+ *ildr5 dang]\sly ill & rev]s+      
progress 9 conta9+ ,,covid-#ai1 %[s :y  
no "o is safe until ev]yone is safe2    
,:]eas ! mismat* betwe5 ! crisis fac$ & 
failure to date to deliv] on ! concrete 
actions ne$$ to end ! p&emic is disa/r\s
 & unacceptable2 ,:]eas new v>iants may 
prolong ! ,,covid-#ai crisis1 & ! next  
v>iant c\ld be ! mutation t makes       
,,covid-#ai vacc9es ineffective & causes
 untold h>m & suff]+2 ,:]eas ! only way 
to end ! p&emic & safegu>d ,am]icans'   
heal? & economic security is = ! ,unit$ 
,/ates ,gov]nm5t to deliv] on ,presid5t 
,bid5's pl$ge to save lives worldwide by
 lead+ ! global ,,covid-#ai vacc9ation  
ef=t1 includ+ by specifically a*iev+ !  
,presid5t's goal ( #gj p]c5t global     
,,covid-#ai vacc9ation by ! ,unit$      
,nations ,g5]al ,assembly 9 ,septemb]   
#bjbb2 ,:]eas less ?an #h p]c5t ( !     
entire population ( ! ,african cont95t  

is vacc9at$ aga9/ ,,covid-#ai1 & mo/    
,african nations are n project$ to rea* 
#aj p]c5t ,,covid-#ai vacc9ation 9      
#bjba2 ,:]eas less ?an #e p]c5t ( p 9   
develop+ c\ntries h receiv$ at lea/ #a  
dose1 & _m 9 develop+ nations w n h     
access to ,,covid-#ai vacc9ation until  
#bjbc abs5t significant increases 9     
,,covid-#ai vacc9e production &         
di/ribution2 ,:]eas abs5t a major       
increase 9 global production & supply ( 
,,covid-#ai vacc9es1 treatm5ts1         
diagno/ic te/s1 & o!r ,,covid-#ai-relat$
 m$ical supplies1 ! p&emic w rage l>gely
 unmitigat$ among a significant %>e ( ! 
_w's population1 result+ 9 fur!r        
mutation ( ! virus & increas$           
hospitalizations & dea?s2 ,:]eas        
,,covid-#ai has kill$ #a out ( #ejj     
,am]icans1 & ! ,delta v>iant elevat$ !  
global daily dea? tolls to #aj1jjj p    
daily2 ,:]eas ,,covid-#ai is e/imat$ to 
cause ! ,unit$ ,/ates                   
#af1jjj1jjj1jjj1jjj 9 economic losses1  
accompani$ by global losses t h         

impov]i%$ hundr$s ( millions ( p        
worldwide2 ,:]eas produc+ & deliv]+ _m m
 doses ( an effective ,,covid-#ai vacc9e
 is ! only pa? to eradicate ?is virus & 
end ! p&emic ev]y:]e2 ,:]eas ri*        
c\ntries h yet to donate adequate am\nts
 ( ,,covid-#ai vacc9es to l[- &         
middle-income c\ntries1 z less ?an #ae  
p]c5t ( ! #a1igj1jjj1jjj doses pl$g$ h  
actually be5 deliv]$2 ,:]eas an e/imat$ 
#aa1jjj1jjj1jjj ,,covid-#ai vacc9es 7   
ne$$ to vacc9ate #gj p]c5t ( ! _w's     
adults1 & dem& has s9ce increas$ ) "s   
nations initiat+ boo/] programs & *ild  
,,covid-#ai vacc9ation plans2 ,:]eas a  
major cause ( ! %ortage is monopoly     
control ( h[ mu* & :]e ,,covid-#ai      
vacc9es are made by a h&ful (           
ph>maceutical corporations t h          
consolidat$ _! control us+ intellectual 
prop]ty b>ri]s2 ,:]eas volunt>y lic5s+  
arrangem5ts h n fix$ ?is problem giv5 ! 
h&ful ( ph>maceutical corporations t are
 us+ intellectual prop]ty monopolies to 
limit production & supply1 & h refus$ to

 negotiate paym5t t]ms ) qualifi$       
manufactur]s 9 ,africa1 ,lat9 ,am]ica1 &
 ,asia creat+ production bottl5ecks &   
?w>t+ production ( ,,covid-#ai vacc9e   
doses ar\nd ! _w2 ,:]eas ,,covid-#ai    
vacc9e monopoly firms are focus$ n on   
global access1 b on pr(itable m>kets1 z 
demon/rat$ by curr5t produc]s prioritiz+
 deliv]y ( boo/] doses sold at increas$ 
prices 9 weal?y c\ntries :ile mo/ ( !   
_w's population rema9s unvacc9at$ aga9/ 
,,covid-#ai2 ,:]eas ! ,,covax initiative
 aims to only vacc9ate #bj p]c5t ( !    
population aga9/ ,,covid-#ai 9 develop+ 
nations by ! end ( #bjba1 & is unable to
 get en\gh supply to meet ?is mode/     
goal2 ,:]eas p ar\nd ! globe *e]$ :5    
,presid5t ,bid5 ann\nc$ ,unit$ ,/ates   
support = ! tempor>y waiv] ( "s ,_w     
,trade ,organization 7,,wto7 ,agreem5t  
on ,trade-,relat$ ,aspects (            
,intellectual ,prop]ty ,rights 7,,trips7
 rules2 ,:]eas 9 response to !          
,bid5-,h>ris adm9i/ration ann\nc+       
support = a tempor>y ,,covid-#ai em]g5cy

 waiv] ( ,,wto intellectual prop]ty     
b>ri]s1 n[ m ?an #acj nations support a 
waiv] ( ,,wto intellectual prop]ty      
monopolies = ph>maceutical corporations2
 ,:]eas ,g]many _h pu%$ ! ,european     
,union to oppose a tempor>y ,,wto waiv]1
 & jo9$ only by ! ,unit$ ,k+dom &       
,switz]l&1 ! #c ,,wto memb]s are block+ 
! re/ ( ! _w's nations t seek to end a  
few ph>maceutical corporations' monopoly
 control ( ,,covid-#ai m$ic9es2 ,:]eas  
!re has be5 no progress made 9 agree+ to
 a f9al ,,wto ,,trips waiv] text s9ce ! 
waiv] 0 initially propos$ on ,octob] #b1
 #bjbj1 & e week a waiv] is n agre$ to  
prolongs ! p&emic2 ,:]eas break+        
monopoly control ov] production n only  
means m ,,covid-#ai vacc9es1 b x also w 
resolve ,,covid-#ai vacc9e supply *a9   
%ortfalls2 ,:]eas af=dable access c be  
quickly scal$ up = ! new antiviral      
,,covid-#ai treatm5ts t dramatically    
r$uce dea? & s]i\s illness giv5 t1 z    
small molecule drugs1 !y c be spe$ily   
produc$ by manufactur]s & di/ribut$     

?r\gh networks already function+ =      
,,hiv_/,,aids m$ic9es if intellectual   
prop]ty b>ri]s are elim9at$ ?r\gh       
enactm5t ( a ,,trips waiv]2 ,:]eas to   
mo/ quickly translate enactm5t ( a      
tempor>y ,,covid-#ai em]g5cy ,,trips    
waiv] into m ,,covid-#ai vacc9e %ots 9  
arms1 m diagno/ic te/s detect+ outbreaks
 & v>iants1 & m treatm5ts to help save  
lives1 ! ,unit$ ,/ates mu/ "w ) ,s\?    
,africa & o!r nations support+ a waiv]  
to conclude a f9al text s a waiv] c be  
enact$2 ,:]eas to mo/ quickly translate 
! lift+ ( ,,trips-impos$ intellectual   
prop]ty b>ri]s into billions (          
,,covid-#ai vacc9e %ots 9 arms1 ! ,unit$
 ,/ates mu/ lev]age ! public inve/m5t 9 
rese>*1 developm5t1 & prepur*ase (      
,,covid-#ai vacc9es & ex]cise its exi/+ 
rights & au?orities to require !        
,,covid-#ai vacc9e monopoly firms to %>e
 recipes via spe$y te*nology transf]2   
,:]eas inve/m5ts 9 int]national         
,,covid-#ai vacc9e manufactur+ hubs &   
infra/ructure promote ,unit$ ,/ates     

heal? security1 economic recov]y1 &     
national security1 & protect ,am]icans f
 ?is p&emic & bett] prep>e ! ,unit$     
,/ates = future p&emics2 ,:]eas keep+   
,am]icans safe f ,,covid-#ai &          
revitaliz+ ! ,am]ican economy to build  
back bett] rely on p worldwide hav+     
access to ,,covid-#ai vacc9es1 diagno/ic
 te/s1 !rapeutics1 & treatm5ts z quickly
 z possible2 & ,:]eas a tempor>y ,,trips
 waiv] does n ?reat5 giv+ ,unit$ ,/ates 
m,r,n,a te*nology to ,*9a & ,russia     
because su* rese>* has already be5      
conduct$ by sci5ti/s ar\nd ! _w =       
decades1 & ! pat5ts on !                
,pfiz]-,bio,n,tech ,,covid-#ai vacc9e   
are lic5s$ to ! ,*9ese firm ,fosun      
,ph>ma to manufacture t ,,covid-#ai     
vacc9e = sale 9 ,*9a3 ,n[1 !re=e1 be x  
,t x is ! s5se ( ,congress t to ensure !
 spe$ie/ end ( ! ,,covid-#ai p&emic--   
7#a7 ,unit$ ,/ates & ,european gov]nm5ts
 %\ld unite to enact a ,_w ,trade       
,organization 7,,wto7 ,agreem5t on      
,trade-,relat$ ,aspects ( ,intellectual 

,prop]ty ,rights 7,,trips7 waiv]1       
require te*nology transf]1 & o!rwise    
facilitate access 9 l[- & middle-income 
c\ntries to high-quality ,,covid-#ai    
m,r,n,a vacc9es2  7#b7 vital ,unit$     
,/ates p>tn]s1 ) %>$ values :o also     
prioritize global coop]ation & sav+     
lives & livelihoods worldwide1 %\ld     
unite to remove all ob/acles to global  
access to ,,covid-#ai vacc9es1          
diagno/ics1 treatm5ts1 oxyg51 & o!r     
m$ical products to advance ! common goal
 ( quickly end+ ! ,,covid-#ai p&emic2   
7#c7 ! ,unit$ ,/ates ,gov]nm5t %\ld play
 its indisp5sable lead]%ip role to "w ) 
,s\? ,africa & o!r nations to quickly   
f9alize a ,,wto ,,trips waiv]1 ov]come !
 opposition n[ block+ ! #acj nations t  
support a waiv]1 & secure swift adoption
 ( a tempor>y ,,covid-#ai waiv] ( !     
pat5t1 copyright1 indu/rial design1 &   
undisclos$ data provisions ( ! ,,wto    
,,trips ,agreem5t ) respect to          
,,covid-#ai vacc9es1 treatm5ts1         
diagno/ic te/s1 & o!r m$ical products to

 prev5t1 conta91 or treat ,,covid-#ai & 
! inputs & equipm5t to make su* m$ical  
products1 s t ,,wto rules no long] ?w>t 
o!rs c\ntries' wid] production (        
,,covid-#ai m$ic9es2  7#d7 ! ,unit$     
,/ates ,gov]nm5t %\ld lev]age its       
massive taxpay] inve/m5ts 9 ,,covid-#ai 
vacc9e developm5t & use exi/+ legal     
au?orities "u ! ,def5se ,production     
,act1 ,bayh-,dole ,act1 & section #adih 
( title #bh1 ,unit$ ,/ates ,code1 to    
compel ,,covid-#ai vacc9e mak]s to %>e !
 ,,covid-#ai vacc9e recipe ) will+1     
qualifi$ companies ar\nd ! _w = a fair  
royalty fee s m doses c be made z       
quickly z possible2  7#e7 ! ,unit$      
,/ates ,gov]nm5t %\ld laun* & help fund 
a global manufactur+ plan to increase & 
democratize ,,covid-#ai vacc9e          
production 9 regional hubs ar\nd ! _w to
 produce #h1jjj1jjj1jjj m ,,covid-#ai   
vacc9e doses by repurpos+ exi/+         
facilities & build+ new capacity1       
includ+ by allocat+ funds to capital    
exp5ditures to e/abli% additional       

,,covid-#ai m,r,n,a vacc9e manufactur+  
l9es & provid+ fund+ = raw mat]ials1    
te*nology transf]1 & royalty co/s to    
scale up production & %ave ye>s f !     
global p&emic2 &  7#f7 ! ,unit$ ,/ates  
,gov]nm5t has an obligation to !        
,am]ican p1 ^: taxpay] funds help$ to   
develop ^! lifesav+ ,,covid-#ai vacc9es1
 to ensure t doses are ultimately       
deliv]$ to ^? mo/ 9 ne$ ar\nd ! _w s z  
to ensure ! global ,,covid-#ai          
vacc9ation t is necess>y to end !       
p&emic4